News items Obesity increases risk of death in uterine cancer
22 April 2021

The biggest risk factor for getting uterine cancer is being overweight or severely overweight (obesity). Research by Hannah Donkers, PhD candidate at the Radboudumc, shows that obesity also causes a worse survival rate in women with uterine cancer. In addition, it appears that lower socioeconomic class and anemia also contribute. 

BMI does not provide complete information

Every year in the Netherlands, approximately 2000 women are told that they have uterine cancer. This makes it the most common gynecological cancer in the Western world. To determine whether a woman is overweight, the Body Mass Index (BMI) is usually used. However, BMI does not look at fat distribution or muscle mass. Hannah Donkers' research shows that women with a lot of visceral fat (fat around your organs) and obesity combined with little muscle mass have a higher chance of dying from uterine cancer. She therefore argues for a broader view on obesity: "By not only looking at BMI, but also at the fat distribution and muscle mass, we can better guide patients and offer a specialized training program with dietary advice. As a result, we can hopefully improve the survival rates of these women."

Following America

Because of smears and HPV vaccination, cervical cancer is very well known, while uterine cancer is more common. In addition, many people do not know that obesity is the biggest risk factor for getting uterine cancer and also causes a decreased survival. That obesity causes high blood pressure, diabetes and cardiovascular disease is often known, but the relationship with uterine cancer is not yet. "Although there are not as many people in the Netherlands who are (morbidly) obese as in America, it is going in the same direction. The obesity pandemic may well cause more healthcare costs and problems than the COVID-19 pandemic" says Donkers. What's her advice? "If you have abnormal vaginal bleeding, get tested. Especially if you are overweight. If you catch it early, uterine cancer is more treatable."

Hopeful future

Donkers' research also reveals a hopeful prospect: a new diagnostic method. A urine test may be able to speed up and facilitate the diagnosis of uterine cancer in the future. By looking in urine for the presence of microRNA, tiny particles of a person's genetic material, uterine cancer may be able to be detected. These specific RNA particles play an important role in the development of obesity and are seen in many different diseases, including cancer. Such a test can remove a lot of stress for this target group. Donkers: "How nice would it be if women no longer had to endure the tedious examinations and biopsies and only had to pee in a cup for a reliable diagnosis? More research is needed, but the first stones have been laid."

About the PhD defense

Thesis: Endometrial cancer; obesity-related carcinogenesis and diagnostic innovations.

Promotor is Professor R.L.M. Bekkers and Copromotor Dr J.M.A. Pijnenborg. The research took place at the Royal Cornwall Hospital, Truro, Cornwall, England under the supervision of miss Khadra Galaal and was financially supported by the Ruby and Rose Foundation Hannah Donkers will receive her PhD on April 22 at 12:30 at the Radboudumc/ Radboud University. Her PhD can be followed live here.

Related news items

Rosella Hermens appointed professor of Person-centered oncological integrated care

7 April 2022

Rosella Hermens has been appointed Professor of Person-centered oncological integrated care at Radboud university medical center/Radboud University. She investigates how care for patients with cancer can become more person-centered and better organized, while the patient remains in control.

read more

Most COVID-19 ICU survivors experience symptoms one year after ICU admission Publication in JAMA

25 January 2022

75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU. This shows the large-scale MONITOR-IC study led by Radboudumc.

read more

1.4 million euro to reduce hospital admissions due to medication

7 January 2022

A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions.

read more

Telemonitoring in chronic heart failure not unqualifiedly positive often additional demand for care without decreasing number of admissions

19 October 2021

To contain rising healthcare costs, digitization of healthcare is often seen as a solution. Researchers at the Radboudumc examined the use of telemonitoring in chronic heart failure. Does this reduce hospital admissions and visits to the emergency room?

read more

Research into treatment for bladder pain syndrome will now be reimbursed

4 August 2021

Bladder pain syndrome, also called interstitial cystitis, is a chronic benign condition of the urinary bladder

read more